Xiao Ming Xu

What is he best known for?

The fields of study he is best known for:

• Gene
• Internal medicine
• Central nervous system

Xiao Ming Xu spends much of his time researching Spinal cord, Spinal cord injury, Neuroscience, Schwann cell and Transplantation. His Spinal cord study combines topics from a wide range of disciplines, such as White matter, Regeneration, Central nervous system and Anatomy. His Spinal cord injury research integrates issues from Lesion, Pathology, Central nervous system disease, Transcription factor and Corticospinal tract.

His work carried out in the field of Neuroscience brings together such families of science as Neurotrophic factors, microRNA and Pathogenesis. His Schwann cell study integrates concerns from other disciplines, such as Neurotrophin, Retrograde tracing, Cord, Gliosis and Dorsal root ganglion. His studies deal with areas such as Grey matter and Cell biology as well as Transplantation.

His most cited work include:

• Axonal regeneration into Schwann cell‐seeded guidance channels grafted into transected adult rat spinal cord (477 citations)
• A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. (425 citations)
• Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord (337 citations)

What are the main themes of his work throughout his whole career to date?

Xiao Ming Xu mostly deals with Spinal cord injury, Spinal cord, Neuroscience, Anatomy and Central nervous system. His Spinal cord injury research incorporates elements of Anesthesia, Internal medicine, Neuroprotection, Transplantation and Pathology. His Spinal cord study combines topics in areas such as Lesion, Neurotrophic factors, Schwann cell, Corticospinal tract and Cord.

Xiao Ming Xu has researched Neuroscience in several fields, including Neurite, Neurotrophin and Regeneration, Cell biology. Xiao Ming Xu usually deals with Cell biology and limits it to topics linked to Cell culture and Embryo. Xiao Ming Xu interconnects Laminectomy, Gliosis and Central nervous system disease in the investigation of issues within Anatomy.

He most often published in these fields:

• Spinal cord injury (59.93%)
• Spinal cord (59.23%)
• Neuroscience (38.33%)

What were the highlights of his more recent work (between 2015-2021)?

• Spinal cord injury (59.93%)
• Spinal cord (59.23%)
• Neuroscience (38.33%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Spinal cord injury, Spinal cord, Neuroscience, Anesthesia and Neuroprotection. The study incorporates disciplines such as Functional recovery, Anatomy, Atrophy, Pathology and Glial cell line-derived neurotrophic factor in addition to Spinal cord injury. His Spinal cord research focuses on Laminectomy in particular.

His Neuroscience study incorporates themes from Regeneration and Corticospinal tract. His study in Anesthesia is interdisciplinary in nature, drawing from both Head trauma and Ischemia. The Neuroprotection study combines topics in areas such as Excitotoxicity and Programmed cell death.

Between 2015 and 2021, his most popular works were:

• The mTOR substrate S6 Kinase 1 (S6K1) is a negative regulator of axon regeneration and a potential drug target for Central Nervous System injury (43 citations)
• The p53 Pathway Controls SOX2-Mediated Reprogramming in the Adult Mouse Spinal Cord (39 citations)
• Label-Free Vibrational Spectroscopic Imaging of Neuronal Membrane Potential. (26 citations)

In his most recent research, the most cited papers focused on:

• Gene
• Internal medicine
• Neuron

Spinal cord injury, Neuroscience, Spinal cord, Neuroprotection and Anesthesia are his primary areas of study. The concepts of his Spinal cord injury study are interwoven with issues in Functional recovery, Anatomy, Atrophy and Cord. His Neuroscience research is multidisciplinary, relying on both Lumbar and Regeneration.

Xiao Ming Xu has included themes like Lesion, Pathology, Neurotrophin and Astrocyte in his Spinal cord study. His Neuroprotection research is multidisciplinary, incorporating perspectives in Inflammation and Excitotoxicity, Programmed cell death. His biological study spans a wide range of topics, including Glial cell line-derived neurotrophic factor, Neurotrophic factors, Spinal Cord Regeneration and Axon.